The neurotoxicity of 3 non-NMDA glutamate receptor agonists-kainate, cy-amino-3-hyclroxy-5-methyl-4-isoxazolepropionate (AMPA), and quisqualate-was investigated quantitatively in dissociated murine cortical cultures. Five minute exposure to 500 @I kainate, but not AMPA, produced widespread acute neuronal swelling. Kainate-induced swelling was resistant to 2-amino-5-phosphonovalerate (APV) or replacement of extracellular sodium with choline but attenuated by either kynurenate or low concentrations of quisqualate. Unlike NMDA agonists, kainate or AMPA did not produce much late neuronal loss after a 5 min exposure.
In contrast, 5 min exposure to 500 PM quisqualate produced both acute neuronal swelling and widespread late neuronal degeneration.
This acute swelling was blocked by APV or by replacement of extracellular sodium by choline, consistent with mediation by NMDA receptors; we speculate that high concentrations of quisqualate may directly activate NMDA receptors or induce the release of endogenous glutamate. Quisqualate-induced late neuronal degeneration may be due to another unexpected process: cellular quisqualate uptake and delayed release, converting brief addition into prolonged exposure.
Hours after thorough washout of exogenously added quisqualate, micromolar concentrations could be detected in the bathing medium by high performance liquid chromatography.
With lengthy exposure (20-24 hr), all 3 non-NMDA agonists were potent neurotoxins, able to destroy neurons with ECso's of about 20 PM for kainate, 4 ELM for AMPA, and 1 NM for quisqualate.
Kynurenate and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), but not APV or L-glutamate diethyl ester, were effective in attenuating the neuronal degeneration induced by these agonists. CNQX was about 3 times more selective than kynurenate against kainate-induced neuronal injury, but CNQX was still nearly equipotent with APV against NMDAinduced injury. Gamma-D-glutamylaminomethyl sulfonate exhibited partial antagonist specificity for AMPA-induced toxicity.
The neuroexcitatory and neurotoxic effects of the amino acid neurotransmitter glutamate are mediated by several types of postsynaptic receptors, commonly referred to by the preferred agonists NMDA, kainate, and quisqualate (Foster and Fagg, 1984; Watkins and Olverman, 1987) . More recently, it has become apparent that quisqualate activates 2 types of receptors: one selectively activated by the agonist oc-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) and directly opening a membrane ionophore (the AMPA/quisqualate receptor) (Krogsgaard-Larsen et al., 1980; Honor? et al., 1982) ; the other acting via G-proteins to activate phospholipase C (the "metabotropic" quisqualate receptor) (Sladeczek et al., 1985; Nicoletti et al., 1986; Sugiyama et al., 1987 ; see also Eccles and McGeer, 1979) .
Kainate and AMPA/quisqualate receptors, which probably mediate most fast excitatory synaptic transmission in the CNS (Mayer and Westbrook, 1987) , mediate a majority share of both glutamate neuroexcitation and glutamate-induced acute neuronal swelling in cortical cultures . However, NMDA receptors may critically mediate the eventual neuronal degeneration induced by brief glutamate exposure . In part, this may be due to the high affinity of glutamate for NMDA receptors (Olverman et al., 1984) . In addition, NMDA receptors alone open membrane channels with high calcium permeability (MacDermott et al., 1986) , and thus may directly trigger a toxic influx of extracellular calcium (Choi, 1987) . Consistent with key involvement of NMDA receptors in glutamate neurotoxicity, selective NMDA antagonists reduce the neuronal injury associated with several types of insults (Rothman and Olney, 1987; Choi, 1988) including ischemia (Simon et al., 1984) hypoglycemia (Wieloch, 1985) hypoxia and trauma (Faden and Simon, 1988) .
Nonetheless, extensive data obtained both in vivo and in vitro suggest that excess stimulation of non-NMDA receptors can suffice to destroy neurons (Coyle et al., 1981; Rothman and Olney, 1987; Frandsen et al., 1989; Mattson et al., 1989) . The contribution of non-NMDA receptors to acute glutamate neurotoxicity may be relatively minor, at least on most mature cortical or hippocampal neurons, but these receptors could be important under other conditions-for example, in other brain regions, during chronic neurotoxic exposure, or during exposure to selective non-NMDA agonists. Indeed, certain neuronal subpopulations may be more vulnerable to injury mediated by non-NMDA receptors than by NMDA receptors. Neurons containing high concentrations of the enzyme NADPH-diaphorase represent one such population in neocortex Koh and Choi, 1988b) or striatum (Koh and Choi, 1988a) .
Although no selective non-NMDA agonist endogenous to the CNS has yet been found, it is possible that the co-release of Zn2+ with glutamate could approximate such an agonist Koh and Choi, 1988~) . Alternatively, a non-NMDA agonist could be supplied exogenously; ingestion of the plant non-NMDA receptor agonist, @-N-oxalylamino-L-alanine (BOAA) causes lathyrism, a chronic neurodegenerative disease affecting motoneurons (Olney et al., 1976; MacDonald and Morris, 1984; Spencer et al., 1986) . Selective damage to motoneurons in monkeys and possibly in man (Guam amyotrophic lateral sclerosis-Parkinsonism-dementia) may be induced by ingestion of the related compound, fl-N-methylamino-L-alanine (BMAA) (Spencer et al., 1987) . While millimolar concentrations of BMAA clearly activate NMDA receptors, it is possible that the lower concentrations may preferentially activate non-NMDA receptors (Weiss et al., 1989b) . Observations with these plant amino acid toxins raise the possibility that non-NMDA receptors may participate in the pathogenesis of certain sporadic neurodegenerative diseases, for example, the sporadic form of amyotrophic lateral sclerosis, or even Alzheimer's disease (Choi, 1989; Greenamyre and Young, 1989) .
There is at present little quantitative data relevant to non-NMDA receptor-mediated neurotoxicity at the cell level. In the present study, we characterized the neurotoxicity of the 3 prototypical non-NMDA agonists-kainate, quisqualate, and AMPA-on cultured murine cortical neurons, using approaches previously used to study the neurotoxicity of glutamate in the same system ). An abstract has appeared .
Materials and Methods
Cortical cell cultures. Mixed cortical cell cultures, containing both neuronal and glial elements, were prepared as previously described from fetal mice at 14-17 d gestation. Dissociated cortical cells were plated in Primaria (Falcon) 15 mm multiwell vessels (about 0.4 x lo6 cells/well) in Eagle's minimal essential medium (MEM, Earle's salts) supplemented with 10% heat-inactivated horse serum, 10% fetal bovine serum, glutamine (2 mM), and glucose (lo-20 mM). Cultures were kent at 37°C in a humidified CO,-containing incubator (initial pH 7.4). After 5-10 d in vitro, non-neuronal cell div&ion was halted by-l-3 d of exposure to 1 Om* M cytosine arabinoside, and the cells were shifted into a maintenance medium identical to the plating media, but lacking fetal serum. Subsequent media replacement was carried out twice per week. Only mature (14-24 d in vitro) cortical cultures were selected for study; key comparisons were made on sister cultures derived from a single plating.
Exposure to excitatory amino acids. Exposure to excitatory amino acids was via the bathing medium, utilizing defined solutions lacking serum, glutamate, or lactate dehydrogenase. Care was taken to wash out the normal medium from cultures prior to addition of excitatory amino acid exposure solutions. One of two different exposure protocols was selected depending on exposure length. Long exposures (> 30 min) were carried out in the culture incubator, using a defined medium consisting of MEM supplemented only with glucose (total, 25 mM). In control experiments, this simplified culture medium was well tolerated by cortical cell cultures for several days.
Brief exposure to excitatory amino acids (30 min or less) was carried out in room air, using a Tris-buffered salt solution with the following composition (in mM): NaCl 120; KC1 5.4; MgCl, 0.8; CaClz 1.8; TrisCl (pH 7.6 at 25"C), 25; glucose 15. Exposure was terminated by washing out-the exposure solution thoroughly and replacing it with MEM plus elucose (25 mM). urior to returning the dishes to the 37°C incubator. Little or%no cor&al cell damage was produced by this protocol if excitatory amino acids were omitted.
NADPH-diaphorase histochemistry. Staining for NADPH-diaphorase was carried out on fixed cultures (30 min in 4% paraformaldehyde at room temperature) (Scherer-Singler et al., 1983) . Cultures were incubated in medium containing 1 mM NADPH (Sigma) and 0.2 mM nitroblue tetrazolium in 0.1 M-Tris buffer (pH 8.2) at 3?C for 30 min to 1 hr. The staining reaction was terminated by washing with water.
Assessment of neuronal injury. Overall neuronal cell injury was estimated in all experiments by examination of cultures with phase-contrast microscopy at 100-400 x . This examination was usually performed 1 d after excitatory amino acid exposure, at which point the process of cell death was large!y complete; previous experience has suggested that the excitatory amino acid-induced injury of cultured cortical neurons and glia can reliably be estimated in this fashion. In some experiments, this examination was verified by subsequent bright-field examination of trypan blue staining (0.4% for 5 min), a dye staining debris and nonviable cells.
In most experiments, overall neuronal cell injury was also quantitatively assessed by the measurement of lactate dehydrogenase (LDH), released by damaged or destroyed cells, in the extracellular fluid 1 d after excitatory amino acid exposure . A small amount of LDH was always present in the media of cultures carried though the exposure protocol but without addition of excitatory amino acids. This background amount, determined on sister cultures within each experiment, was subtracted from values obtained in treated cultures. Control experiments showed that the specific efflux of LDH induced by glutamate exposure (after background subtraction) was linearly proportional to the number of neurons damaged or destroyed and that no specific LDH efflux occurred when pure cultures of cortical glia were similarly exposed to glutamate .
The absolute value of the LDH efflux produced by a given excitatory amino acid exposure was quite consistent within sister cultures of a single plating, but differed somewhat between platings, largely as a function of neuronal density (which varied despite constant original mating densities, presumably reflecting small variations in cell preparaiion or serum characteristics). Therefore, each observed LDH value was scaled to the mean value produced by exposure to high concentrations of some specified excitatory amino acid in other sister cultures.
Staining of cultures for NADPH-diaphorase unequivocally labeled a small, scattered subpopulation of neurons, making it feasible to simply count the total number of labeled neurons in each well (40-200 neurons in control wells) using low-power (100 x) bright-field optics and confirmatory high-power (400 x) examination as necessary. Damage to the NADPH-diaphorase-containing neuronal subpopulation was measured as the difference between the mean number of cells in several untreated control wells and the mean number of cells in experimental cultures, expressed as a percentage of the former.
Calculation for PA,. PA, values for kynurenate were estimated with the following equation (Arunlakshana and Schild, 1959) :
where EC&,, is the agonist concentration that produces half-maximal LDH release in the presence of kynurenate, and EC,,.,,,, is the agonist concentration that produces half-maximal LDH release without kynurenate. EC,, values were estimated from observed concentration-toxicity data. High performance liquid chromatography. Excitatorv amino acid concentrations in media samples were determined by reverse-phase highperformance liquid chromatography (HPLC), usine fluorescence detection (Lindroth and Mopper, 1979 ) and gradient conditions as described by Connick and Stone (1988) . Sample aliquots (50 ~1) were mixed with 100 ,111 o-phthaldialdehyde (OPT)/2-mercaptoethanol reagent (Sigma). After 1 min, 100 ~1 ofthis mixture was injected onto the analytic column (Cl8 p-Bondapak column fitted with Cl 8 precolumn, Waters). Phosphate buffer (pH 7.2) : water : acetonitrile (solvent A) and water : acetonitrile : methanol (solvent B) were prepared using HPLC-grade reagents, and eluted in the following gradient program (O/o solvent B): 0 min (0) 2 min (0) 12 min (100). The flow rate was 1.5 ml/min.
OPT derivatives of aspartate, glutamate, and quisqualate were identified by their retention times, and concentrations quantified by peak height comparisons to an amino acid standard solution containing 40 amino acids (Sigma) and quisqualate (2.5 PM).
Control experiments showed that this HPLC procedure could resolve aspartate, glutamate, and quisqualate from each other and from the 38 additional amino acid in the standard.
Drugs. AMPA, DL-2-amino-5-phosphonovalerate (APV), y-D-glutamylaminomethyl sulfonate (GAMS), and 6-cyano-7nitroquinoxaline-2,3-dione (CNQX) were purchased from To&s Neuramin. Quisqualate, of both natural and synthetic origin, was obtained from Cambridge Research Biochemicals. Kainate, kynurenate, L-glutamate diethyl ester (GDEE), 4,4'-diisothiocyano-2,2'-disulfonic acid (DIDS), dihydrokainate (DHK), and most other reagents, were obtained from Sigma.
Results
Brief exposure to non-NMDA agonists Cortical cultures exposed for 5 min to 500 PM kainate exhibited dramatic immediate swelling and darkening of neuronal cell bodies under phase-contrast microscopy; however, within an hour after kainate washout, the swelling largely abated. By the next day only a small amount of neuronal damage was evident Figure 1 . Morphological damage produced by brief exposure to kainate, quisqualate, and AMPA. Phase-contrast photomicrographs follow representative fields of cortical neurons in sister cultures, taken before (left column), immediately after (middle), and 20 hr after (right) 5 min exposure to 500 PM kainate (A), 500 PM quisqualate (B), or 500 PM AMPA (C). Quisqualate produced both acute neuronal swelling and extensive late neuronal death, kainate produced only the former; AMPA produced neither. Scale bar, 100 pm. . LDH values were scaled to the mean value found in the G500 condition (= 100). Substantial late neuronal damage was found in the cultures exposed to either natural or synthetic quisqualate; but not AMPA, kainate, or low concentrations of glutamate.
( Fig. 1A) . The same brief exposure to 500 PM AMPA was followed by neither much acute neuronal swelling nor late neuronal loss ( Fig. lc) . Unexpectedly, exposure to quisqualate differed markedly from exposure to AMPA, producing both acute neuronal swelling (slightly less than that induced by kainate) and widespread late neuronal degeneration (Fig. 1B) . In all cases, background glial cells showed little morphological change and retained the ability to exclude trypan blue. Quantitative assessment of the late neuronal damage resulting from these exposures could be accomplished by measuring the efflux of the cytosolic enzyme LDH to the bathing medium 24 hr later. We previously showed that 5 min exposure to 500 FM glutamate or NMDA resulted by the next day in extensive neuronal degeneration and concomitant LDH efflux. Consistent with morphological observations, 5 min exposure to 500 FM kainate or AMPA produced little LDH efflux, but 500 PM quisqualate was roughly equipotent as a neurotoxin to glutamate or NMDA (Fig. 2) .
We considered the possibility that the anomalous neurotoxic efficacy of brief quisqualate exposure might be due to glutamate contamination (Cha et al., 1987) . However, HPLC measurement of the glutamate level in our lot of quisqualate showed only 2% contamination. Even a contamination level as high as 5% would have resulted in a 500 PM quisqualate solution containing only 25 PM glutamate, a concentration too low to produce much in the way of either acute neuronal swelling (not shown) or late neuronal injury (Fig. 2) . In addition, no toxic synergy was produced when 25 PM glutamate was added to 1 mM AMPA (Fig. 2) ; furthermore, synthetically prepared quisqualate lacking detectable glutamate contamination possessed neurotoxicity comparable to that of natural quisqualate (Fig. 2) . Further examination of the basis for the neurotoxicity of brief quisqualate exposure is presented in a separate section below.
The low neurotoxicity of both kainate and AMPA persisted even if exposure times were increased 6-fold to 30 min. Detailed investigation of the dependence of 1 mM AMPA toxicity upon exposure time revealed that exposure times in excess of 1 hr Sister cultures were exposed to 1 mM AMPA for the indicated time. Samples ofbathing media were taken both before washout of AMPA, and 24 hr after the initiation of exposure, and summed to obtain total released LDH (mean + SEM, IZ = 4) scaled to the mean value found in cultures exposed to 1 mM AMPA for 24 hr (=lOO, a value reflecting virtually complete morphological neuronal loss).
were required for reliable destruction of > 25% of the neuronal population (Fig. 3) .
Acute neuronal swelling The neuronal cell body swelling produced acutely by brief kainate or quisqualate exposure was measured quantitatively from photomicrographs taken before and after exposure. As expected, 1 mM APV, a selective NMDA receptor antagonist, produced little reduction in kainate-induced swelling; however, 1 mM APV did block the acute swelling induced by quisqualate (Fig. 4) . In other experiments, the same effects were seen with 500 PM D-APV or with synthetic quisqualate; the latter suggested that this APV sensitivity was not explained by glutamate contamination of the quisqualate used. Like the swelling induced by NMDA agonists , quisqualate-induced swelling could be blocked by substitution of choline for extracellular sodium; in fact, neurons became slightly smaller than those exposed to sham wash alone ( Fig. 5) (p < 0.05, 2-tailed t-test). In contrast, choline substitution had little effect on kainate-induced neuronal swelling (Fig.  5) . Both kainate-and quisqualate-induced swelling were blocked by the broad-spectrum antagonist kynurenate (Fig. 5) .
Interestingly, a low (10 FM) concentration of quisqualate could attenuate the swelling induced by kainate, whereas the reverse was not true (Fig. 5) . AMPA, 500 ELM (which itself produced little neuronal swelling; see Fig. 1 C) , did not attenuate the swelling induced by either 100 PM kainate or 100 PM quisqualate (not shown).
Prolonged exposure to non-NMDA agonists Extending the exposure time from 5 min to 20-24 hr greatly increased the neurotoxicity of kainate, quisqualate, and AMPA. All 3 agonists then produced concentration-dependent neuronal damage and LDH efflux (Fig. 6) ; at high concentrations, all destroyed nearly the entire neuronal population as assessed by morphological criteria. Of the 3, quisqualate was the most potent toxin with EC,, ofabout 1 PM; EC,,'s for AMPA and kainate were about 4 and 20 PM, respectively. The addition of 500 PM kynurenate to the exposure media shifted all 3 curves in parallel Figure 4 . NMDA receptors mediate quisqualate-induced acute neuronal swelling. Bright-field photomicrographs of neurons in sister cultures before and after 20-30 min exposure to 500 PM quisqualate (AI,A2) and 500 WM kainate (B1$2) both in the presence of 1 mM APV. Bars in C indicate mean percentage change (+SEM; n = 36-50 cells) in area of neuronal cell bodies in cultures exposed to quisqualate or kainate, with or without 1 mM APV. Neuronal cell body areas were measured directly from photomicrographs by tracing the outline with a digitizer linked to a microcomputer. APV substantially attenuated quisqualate-induced, but not kainate-induced, swelling. Scale bar, 50 pm. Statistical assessment of APV effect was by 2-tailed t-test. fashion to the right, producing EC,,% of about 10 PM for quisqualate toxicity. Partial (about 30%) reduction of kainate or qualate, 15 FM for AMPA, and 85 KM for kainate. The finding quisqualate toxicity was seen with 1 mM GAMS (not shown). that the protective effect of kynurenate could be overcome by Even at only 10 PM, CNQX produced a marked reduction in increasing agonist concentration is consistent with competitive the neuronal injury induced by all 3 agonists. Control experiantagonism. Calculated pA, values of kynurenate were 4.1 for ments verified that no antagonist was intrinsically toxic with quisqualate, 3.7 for AMPA, and 3.8 for kainate.
the tested exposures. Several other excitatory amino acid antagonists-APV, GAMS, GDEE, and the novel non-NMDA antagonist CNQX (Honore et al., 1987) -were screened against the neuronal injury caused by 24 hr exposure to 3 PM quisqualate, 30 MM kainate, or 10 KM AMPA (Fig. 7) . These agonist concentrations were chosen to induce quantitatively similar, submaximal amounts of neuronal damage (see Fig. 6 ). APV or GDEE, both 500 PM, produced little protective effect. GAMS, 500 PM, significantly reduced AMPA toxicity but had little effect on kainate or quisSelectivity of excitatory amino acid antagonists The selectivity of CNQX as an antagonist of excitatory amino acid neurotoxicity was compared with that of the broad spectrum antagonist kynurenate and the NMDA antagonist APV. Cultures were exposed for 24 hr to 30 KM NMDA or 30 PM kainate, threshold concentrations just sufficient to destroy the majority of the neuronal population in the absence of antagonist (Koh and Choi, 1988b) . Addition of CNQX, kynurenate, or Pharmacology of non-NMDA receptor-induced acute neuronal swelling. Bars depict the average percentage changes (+SEM, n = 36-80 cells) in neuronal cell area 20 min after the indicated toxic exposures in sister cultures. Concentrations are specified in micromolar; sodium replacement (Na-free) was accomplished with equimolar choline. Asterisk(*) indicates significant difference (p < 0.05) compared with the swelling produced by 100 PM ofthe same agonist alone (2-tailed t-test with Bonferroni correction for 5 comparisons). APV to the exposure solution produced antagonist concentration-dependent reductions in resultant neuronal loss (Fig. 8) .
CNQX was about 100 times more potent than kynurenate in blocking kainate toxicity; IC,,'s against kainate toxicity were about 1 PM for CNQX and 100 PM for kynurenate. However, CNQX also blocked NMDA toxicity 30 times more potently than kynurenate, and actually as potently as APV (both IC,,'s about 10 WM). The observed selectivity ratio, IC,, against NMDA! IC,, against kainate, for CNQX was thus only 10, which was 3.3 times that ofkynurenate (Table 1) . APV showed a selectivity ratio of less than 0.01.
Paradoxical neurotoxicity of brief quisqualate exposure
We considered it puzzling that quisqualate alone could produce widespread neuronal loss after 5 min exposure and sought to find a basis for this paradoxical toxic efficacy. The finding that quisqualate-induced acute neuronal swelling could be blocked by APV raised the possibility that direct or indirect activation of NMDA receptors might be responsible. However, the addition of 500 PM APV to the exposure solution had little effect on the neurotoxicity associated with brief quisqualate exposure, even if the quisqualate concentration were reduced to only 100 FM, a concentration producing submaximal toxicity (Fig. 9) . In similar fashion, addition of 500 PM concentrations of GAMS, GDEE, kynurenate, or even CNQX to the quisqualate exposure solution also did not affect the toxicity of 5 min quisqualate exposure (Fig. 9) . Next, we considered the possibility that brief addition of quisqualate somehow induced a lasting stimulation of excitatory amino acid receptors. If either 500 KM kynurenate or 10 KM CNQX were added to the bathing medium not just during the 5 min quisqualate exposure, but also following quisqualate washout ("continuous" antagonist exposure), marked attenuation of resultant neuronal damage was observed (Fig. 10) . APV, GAMS, and GDEE remained ineffective at 500 PM (Fig. 10 ). Similar protection with 10 PM CNQX was obtained when the CNQX was added only after the quisqualate washout. These observations suggested that the neurotoxicity of brief quisqualate addition was indeed due to lasting activation of non-NMDA receptors.
One way that this might occur would be if quisqualate were not completely washed out at the end of the 5 min exposure. The standard washout procedure produced a calculated 7000-fold dilution of the exposure solution; further increasing washout to a calculated dilution of >300,000 did not alter quisqualate toxicity. This washout should be sufficient to remove quisqualate free in the bathing medium. However, simple washout would not remove quisqualate that was either tightly bound to membrane structures or taken up inside cells. Such protected quisqualate might be later released to the extracellular solution, achieving in effect chronic quisqualate exposure. To test this idea, medium was removed from either mixed neuronal and glial cultures or pure glial cultures, 24 hr after 5 min exposure to quisqualate. Addition of such conditioned medium to other cultures at 1:3 dilution resulted in the destruction ofthe neuronal subpopulation containing the marker enzyme NADPH-diaphorase, a subclass of neurons highly sensitive to non-NMDA receptor-mediated toxicity (Koh and Choi, 1988b) (Fig. 11) . Damage to the general neuronal population was less marked. This toxicity of medium removed from cultures previously exposed to quisqualate was not found in cultures similarly exposed to several other excitatory amino acids, even those mixed cultures exposed to glutamate or NMDA where widespread neuronal cell damage had occurred (Fig. 11) . Furthermore, HPLC measurements on the media of either mixed or glial cultures subjected 24 hr previously to 5 min exposure to 0.5-1.0 mM quisqualate did indeed reveal detectable levels of quisqualate: 2.3 +-0.4 FM (SEM, n = 4) in mixed cultures and 1.0 f 0.1 I.LM (n = 4) in glial cultures (Fig. 12) .
The process responsible for protecting quisqualate from washout might be either tight binding or cellular uptake. Favoring the latter, acute addition of 3 mM concentrations of 2 compounds known to block glutamate uptake-the chloride transport blocker 4,4'-diisothiocyano-2,2'-disulfonic acid (DIDS) (Bridges et al., 1987; Recasens et al., 1987) and dihydrokainate (DHK) (Johnston et al., 1979 )-could attenuate the neuronal damage produced by 5 min quisqualate exposure (Fig. 13 ).
Zinc potentiation of AMPA neurotoxicity
Zinc potentiates the neuroexcitatory action of both quisqualate and AMPA and increases the neurotoxicity of brief quisqualate exposure . Addition of 100 PM--I mM zinc also produced a concentration-dependent increase in the neuronal injury resulting from a 5 min exposure to 500 PM AMPA; the zinc EC,, for this potentiation was about 200 PM (Fig. 14) . (Kemp et al., 1987) . The novel quinoxaline derivative CNQX (Honor6 et al., 1987) was much more potent than kynurenate in attenuating kainate neurotoxicity, but only several-fold more selective; it was still as potent as APV in attenuating NMDA neurotoxicity in our cultures. Precedent for CNQX as an NMDA antagonist is provided by a report that 6 PM CNQX could noncompetitively block half the maximum NMDA-induced current in Xenopus oocytes injected with rat brain mRNA (Verdoorn et al., 1988) . A possible basis for CNQX antagonism of NMDA receptor activation may be displacement of glycine from its modulatory site on the NMDA receptor complex, a mechanism that may be common to other quinoxalinediones (Birch et al., 1988 ; but see Drejer et al., 1989) . In any case, present observations support the idea that effects of CNQX, especially at concentrations higher than 10 PM, should not be uncritically attributed to the selective antagonism of non-NMDA receptors.
Further study will also be required to define the exact glutamate receptor subpopulations responsible for mediating the neurotoxicity of the tested agonists. A key question is to what extent AMPA and quisqualate activate the same non-NMDA receptor population as kainate. Present observations provide support for the idea that the AMPA activates receptors which are at least partially distinct from those activated by kainate (Monaghan et al., 1983; Greenamyre et al., 1985; Ascher and Nowak, 1988) . Although with chronic exposure, AMPA was a slightly more potent neurotoxin than kainate, it was more sensitive than kainate to antagonism by GAMS. In addition, AMPA neither mimicked nor interfered with kainate-induced acute neuronal swelling. Finally, zinc markedly potentiated AMPA neurotoxicity, in a fashion similar to its potentiation of quisqualate toxicity but greater than its potentiation of kainate toxicity . Pending molecular biological insights, it remains attractive to refer to the receptors activated specifically by AMPA as "AMPA/quisqualate receptors." The inability of AMPA/quisqualate receptor activation (by either AMPA or quisqualate + APV) to induce Figure 6 . Kynurenate competitively antagonizes the neurotoxicity produced by lengthy exposure to non-NMDA agonists. A, Mean LDH (? SEM, n = 4) in the medium after 24 hr exposure of sister cultures to the indicated concentrations of quisqualate either alone or in the presence of 500 PM kynurenate. The toxic EC,, for 24 hr quisqualate exposure alone was about 1 PM; addition of 500 PM kynurenate shifted this concentration-toxicity relationship to the right (EC,, about 10 MM). LDH values were normalized to the mean LDH seen in cultures exposed to the highest concentrations of quisqualate alone. B, Same as A but with AMPA. EC,, for AMPA alone or with kynurenate was about 4 and 15 PM, respectively. C, Same as A but with kainate. EC,, for kainate alone or with kynurenate was about 20 and 85 PM, respectively. acute neuronal swelling might be accounted for by small number, low conductance of the associated ionophore, or partial desensitization. However, these observations cannot exclude the possibility that such an AMPA/quisqualate receptor population overlaps with the kainate receptor population. Indeed, it is likely that quisqualate itself interacts substantially with kainate receptors and NMDA receptors (see below) in addition to AMPA/quisqualate receptors. Quisqualate toxicity was less sensitive to GAMS than was AMPA toxicity. Furthermore, low concentrations (10 PM) of quisqualate attenuated kainate-induced swelling. Quisqualate could act as a kainate antagonist because it has higher affinity but only partial agonist properties at kainate receptors (O'Brien and Fischbach, 1986; Gallo et al., 1989) . Other mechanisms can also be considered; for example, some quisqualate effects could be mediated by the metabotropic quisqualate receptor (Sladeczek et al., 1985; Nicoletti et al., 1986; Sugiyama et al., 1987) .
In contrast to their potency as neurotoxins with prolonged exposure, even millimolar concentrations of kainate or AMPA failed to produce much neuronal cell loss with exposure times under 30 min. This generalization applies only to the cortical Figure 8 . Comparison of the selectivity of CNQX, kynurenate, and APV. Mean LDH (+SEM, n = 4) present in the bathing media after exposure of sister cultures to either 30 PM kainate or 30 FM NMDA 24 hr in the presence of indicated concentrations of CNQX, kynurenate, or APV. Approximate IC,,'s: for CNQX, 1 PM against kainate and 10 PM against NMDA, for kynurenate, 100 PM against kainate and 300 PM against NMDA; for APV, > 1 mM against kainate and 10 PM against NMDA.
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GDEE I +l ON CNPX T I neuronal population as a whole; certain small neuronal subpopulations, for example NADPH-diaphorase-containing neurons, may exhibit heightened vulnerability to injury by non-NMDA agonists (Koh and Choi, 1988b) . While non-NMDA receptor-mediated neurotoxicity has recently been induced by glutamate exposure on cultured cortical neurons (Frandsen et al., 1989) and young cultured hippocampal neurons (Mattson et al., 1989) both studies utilized lengthy (several hour) exposure durations. It can be noted that the resistance of young (5 din culture) hippocampal neurons to NMDA receptor-mediated injury (Mattson et al., 1989 ) is consistent with the resistance of young cortical neurons to injury by brief glutamate exposure .
Kainate did induce widespread acute "excitotoxic" neuronal swelling. For the most part, this swelling was reversible, consistent with our earlier demonstration that 5 min exposure to glutamate in the presence of APV is followed by transient neuronal swelling but little late neuronal degeneration . Another example of a dissociation between acute excitotoxicity and late neuronal degeneration was provided by removing extracellular calcium during toxic glutamate exposure: acute neuronal swelling was increased, but late neuronal cell loss was reduced (Choi, 1987) . The acute neuronal swelling produced by kainate may be due to a large influx of sodium through kainate-activated channels, followed by influx of chloride and water. Nonetheless, brief activation of kainate or AMPA receptors was much better tolerated by most neurons than similar activation of NMDA receptors. The lesser neuronal degeneration produced by brief non-NMDA receptor activation, compared with NMDA receptor activation, may be partly due to the lower calcium permeability of the channels activated by non-NMDA receptors (MacDermott et al., 1986) . Unlike kainate or AMPA, brief exposure to quisqualate produced both acute neuronal swelling and widespread late neuronal destruction. These quisqualate effects were not explained by glutamate contamination. The measured level of contamination in the quisqualate lot used here (2%) was too low to account for either effect, and furthermore, both effects could be produced by synthetic quisqualate lacking measurable glutamate contamination. Instead, data presented here suggest that the neurotoxicity associated with brief quisqualate exposure may be a complex reflection of processes beyond simple transient activation of AMPA/quisqualate or kainate receptors.
The acute swelling produced by quisqualate could be blocked by APV and thus was presumptively mediated by NMDA receptor activation. (Olverman et al., 1984; Greenamyre et al., 1985) , and single-channel recording has shown that quisqualate can open NMDA channels (Ascher and Nowak, 1988) . Alternatively, NMDA receptors might be activated by glutamate or other endogenous NMDA agonists released from neurons stimulated by quisqualate. In any case, quisqualateinduced activation of NMDA receptors was not the major explanation for the late cell loss induced by brief quisqualate exposure, since the latter was not blocked by APV. Consistent with the idea that quisqualate produces acute neuronal swelling by activating NMDA receptors, this swelling could be blocked by the substitution of choline for extracellular sodium, a maneuver previously found to block the swelling induced by selective NMDA agonists ). In contrast, the neuronal swelling induced by kainate was not attenuated by the same procedure. It is possible that kainate-gated channels may be permeable to choline, similar to the channels gated by nicotinic ACh receptors (Dwyer et al., 1980) . Of note, kainategated channels may be larger in pore size than the channels gated by NMDA (Vyklicky et al., 1988) .
Observations here also invoke another process to explain the paradoxical late neuronal loss associated with brief quisqualate Figure IO . Continuous application of kynurenate or CNQX markedly attenuates the toxicity of brief quisqualate exposure. Barsm depict mean-LDH (+SEM. n = 4) released in sister cultures arier 5 mm exposure to 500 FM quisqualate either alone (control) or in the presence of indicated antagonists, added both during and after quisqualate exposure. Asterisk (*) indicates significant difference (p < 0.05) from control by 2-tailed t-test with Bonferroni correction. These results were obtained with natural quisqualate; similar results were obtained with synthetic quisqualate. Figure   11 . Media of cultures previously exposed to quisqualate can damage NADPH-diaphorase-containing neurons. A sample of the bathing medium was taken 24 hr after exposure of sister mixed or glial cultures to 500 PM of indicated agonists for 5 min and added to other mixed cultures (net dilution, 1:3). Then. 24 hr later. the number of NADPH-diaphorase-containing neurons in each well was counted and the percentage loss of these neurons was determined.
FROM MIXED CULTURES exposure: the lasting stimulation of non-NMDA receptors. No tested excitatory amino acid antagonist could block the toxicity of brief quisqualate exposure if added only acutely during the toxic exposure. However, both kynurenate and CNQX were neuroprotective if added additionally in the period after thorough washout of the original exposure solution. The observation that CNQX needed to be present following quisqualate washout in order to block subsequent neuronal injury is consistent with a recent study of Garthwaite and Garthwaite (1989) which examined quisqualate toxicity in the hippocampal slice.
We have suggested that exogenously added quisqualate was protected from washout by cellular uptake and later released into the medium Harris et al., 1987) , effectively achieving an exposure time of many hours . Support for this hypothesis was found in the observation that 24 hr after quisqualate washout, the bathing media removed from either mixed or glial cultures showed low micromolar concentration of quisqualate by HPLC and the ability to destroy NADPH-diaphorase-containing neurons in other test cultures. The fate of NADPH-diaphorase-containing neurons was used here as a sensitive bioassay of non-NMDA receptor-mediated Figure 12 . HPLC determination of the quisqualate present in the media 24 hr after exposure to either quisqualate or glutamate. After 5 min exposure to 1 mM quisqualate or glutamate, cultures were thoroughly washed and incubated overnight in culture medium lacking serum. Then, 24 hr later, the bathing medium was analyzed by HPLC. Amino acid standard solution contained 2.5 PM concentrations of both glutamate (G) and quisqualate (Q) (thick arrows). The quisqualate peak (about 3 PM in this sample) was found only in the media of cultures previously exposed to quisqualate (Post-Quis) but not in cultures previously exposed to glutamate (Post-G/u). Thin arrows indicate the beginning of elution. toxicity. We do not think that the validity of the uptake-late release hypothesis is diminished by the failure of the transferred bathing medium to produce generalized neuronal destruction in the test cultures. Quisqualate concentrations reached in the bath of the original cultures would have been 3-fold higher than in the test cultures due to transfer dilution; furthermore, the actual effective quisqualate concentrations achieved locally near cellular release sites in the original cultures might well have been higher than the concentrations that ultimately accumulated in the bathing medium. Present observations suggest that both neurons and glia in combination, and glia alone, can participate in such quisqualate uptake and late release. Specifically supporting a role for cellular uptake, the acute addition of 2 glutamate uptake inhibitors, DIDS and DHK, attenuated resultant neuronal injury in the brief quisqualate exposure paradigm.
We present in Table 2 a speculative summary of our observations to date with glutamate receptor-mediated injury of cultured cortical neurons. For reasons discussed above, the assumptions are made that AMPA and kainate act on distinct receptors and that the complex effects of quisqualate are ex- plained by interaction with all 3 glutamate receptor subtypes. As a hypothesis subject to future testing, we propose that the neuronal degeneration induced by prolonged exposure to non-NMDA agonists may be largely mediated by a calcium influx triggered secondarily by sodium influx; e.g., through voltagegated channels, reverse operation of the sodium<alcium exchanger, and/or calcium leak conductance due to cell swelling (Choi, 1987) . Calcium dependence of kainate toxicity has been observed in rat cerebellar slices (Garthwaite and Garthwaite, 1986 ) and hippocampal cultures . Voltage-gated calcium channels may be especially important, as 1 O- Choi et al. (1988) . " High-affinity but partial agonism, effective antagonist. " Weak agonist. 100 WM nifedipine partially reduced the toxicity of 24 hr exposure to either AMPA or kainate in our cortical cultures (Weiss et al., 1989a) , and GABA plus diazepam blocked non-NMDA receptor-mediated injury to young hippocampal neurons (Mattson et al., 1989) .
The role that non-NMDA receptors may play in disease pathogenesis will be another topic suitable for future exploration. Brief intense activation of non-NMDA receptors appears to be better tolerated than similar activation of NMDA receptors; thus, non-NMDA receptors may be less important than NMDA receptors in the setting of acute brain injury. However, the high potency with which prolonged stimulation of non-NMDA receptors can destroy neurons could be the substrate for important involvement in certain chronic neurodegenerative states. Figure 14 . Zinc potentiates acute AMPA neurotoxicity. Sister cultures were exposed for 5 min to 500 PM AMPA in the presence of the indicated concentrations ofZr?+ (solid line). Closedcircles show mean LDH (GEM, n = 4) present in the media 24 hr after exposure, scaled to the mean value found in the cultures exposed to AMPA in the presence of 1 mM Zn2+ (= 100, associated with near-complete morphological neuronal destruction). Open circles show the neuronal damage produced by exposure to Zn alone (?SEM, n = 4).
